Savara to Participate in Two Upcoming Investor Healthcare Conferences

Rhea-AI Summary

Savara Inc. (NASDAQ: SVRA), a biopharmaceutical company specializing in rare respiratory diseases, announced its participation in two upcoming healthcare conferences. The company will present a pre-recorded webcast at the Piper Sandler 33rd Annual Virtual Healthcare Conference on November 22, 2021, at 10:00 AM ET. Additionally, a live webcast of a fireside chat will occur during the Evercore ISI 4th Annual HealthCONx Virtual Conference on November 30, 2021, at 8:50 AM ET. The webcasts will be accessible on Savara's investor page for 90 days.

Piper Sandler 33rd Annual Virtual Healthcare Conference

Evercore ISI 4th Annual HealthCONx Virtual Conference

AUSTIN, Texas--(BUSINESS WIRE)-- Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at the following healthcare conferences:

• Piper Sandler 33rd Annual Virtual Healthcare Conference: A pre-recorded webcast of the presentation will be available beginning at 10:00 AM ET / 7:00 AM PT on November 22, 2021.

• Evercore ISI 4th Annual HealthCONx Virtual Conference: A live webcast of a fireside chat will take place at 8:50 AM ET / 5:50 AM PT on November 30, 2021.

Both webcasts will be available through the Investors page of Savara’s website at www.savarapharma.com/investors/events-presentations/ and will be archived for 90 days.

About Savara

Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Our lead program, molgramostim nebulizer solution, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). Molgramostim is delivered via an investigational eFlow® Nebulizer System (PARI Pharma GmbH). Our management team has significant experience in rare respiratory diseases and pulmonary medicine, identifying unmet needs, and effectively advancing product candidates to approval and commercialization. More information can be found at www.savarapharma.com. (Twitter: @SavaraPharma, LinkedIn: www.linkedin.com/company/savara-pharmaceuticals/).

View source version on businesswire.com: https://www.businesswire.com/news/home/20211115005335/en/

Savara Inc. IR & PR

Anne Erickson

Senior Vice President, Chief of Staff

anne.erickson@savarapharma.com

(512) 851-1366

Source: Savara Inc.

FAQ

What is Savara Inc.'s stock symbol?

Savara Inc.'s stock symbol is SVRA.

When will Savara present at the Piper Sandler Healthcare Conference?

Savara will present at the Piper Sandler 33rd Annual Virtual Healthcare Conference on November 22, 2021, at 10:00 AM ET.

What time is Savara's live presentation at the Evercore ISI HealthCONx Conference?

Savara's live presentation at the Evercore ISI 4th Annual HealthCONx Virtual Conference is scheduled for November 30, 2021, at 8:50 AM ET.

Where can I access the webcasts for Savara's conference presentations?

The webcasts for Savara's conference presentations can be accessed through the Investors page on their website.

What is the focus of Savara Inc.?

Savara Inc. focuses on developing treatments for rare respiratory diseases.